New research, presented today at the European Academy of Neurology (EAN) Congress 2025, has uncovered a powerful link between nighttime heart rhythm and future health conditions, even in… read more.
The American College of Cardiology has issued a Concise Clinical Guidance (CCG) document to aid clinicians in the use of medication for weight management in patients where treatment… read more.
Abbott announced the FDA has approved the company’s Tendyne transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. This life-changing therapy is available for… read more.
A new study by Chinese scientists has sparked hope for improved management of sepsis, a potentially life-threatening medical emergency. The research suggests that statins, a commonly-used cholesterol-busting medication,… read more.
Researchers report that in patients with chronic aphasia after stroke, right neurotomy of the seventh cervical nerve (C7) at the intervertebral foramen plus intensive speech and language therapy… read more.
Johnson & Johnson MedTech, announced the U.S. launch of the Soundstar Crystal Ultrasound Catheter for intracardiac echocardiography (ICE) imaging in cardiac ablation procedures. The device provides clearer, enhanced… read more.
The Society of Thoracic Surgeons (STS) has launched a new mobile app that offers surgeons and multidisciplinary medical providers real-time access to its suite of adult cardiac surgery and thoracic… read more.
Amgen announced full results from Part 1 of the Phase II study for MariTide (maridebart cafraglutide, formerly AMG 133) in patients living with obesity, with and without Type… read more.
Medtronic plc announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut transcatheter aortic valve replacement (TAVR) system delivers a… read more.
BridgeBio Pharma Inc. announced that the first asymptomatic participant with a known pathogenic transthyretin (TTR) variant, that may lead to transthyretin amyloid disease (either cardiomyopathy, ATTR-CM, polyneuropathy, ATTR-PN,… read more.
Intensive exercise- and sport changes the heart of an athlete. Research led by Amsterdam UMC shows that the hearts of female athletes have different characteristics than those of… read more.
Liquidia Corporation announced that the FDA has approved Yutrepia (treprostinil) inhalation powder, a prostacyclin analog for adults with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
